by Damon Race | Apr 8, 2025 | In the News
Gene therapy developed at Duke to be commercialized by a local biotechnology company by Fedor Kossakovski Duke University recently signed an exclusive license with GeneVentiv Therapeutics, a Raleigh-based gene therapy company, to commercialize a gene therapy developed...
by Damon Race | Apr 8, 2025 | Press
RALEIGH, N.C., April 8, 2025 /PRNewswire/ — GeneVentiv Therapeutics, a gene therapy company, today announced it has signed a global licensing agreement with Duke University for the first universal gene editing therapy for both infantile-onset and late-onset...
Recent Comments